Dr. Mark A. Vierra, MD

Dr. Vierra practices at Montage Medical Group in Carmel, California.

Dr. Vierra's NPI, 1295706448, was assigned on January 27, 2006. Dr. Vierra graduated from Harvard Medical School in 1985. Dr. Vierra holds California license G59649.

Dr. Vierra's primary practice is Montage Medical Group, at 275 Crossroads Blvd, Carmel, CA 93923 in Monterey County. The practice phone is (831) 658-3639.

Dr. Vierra's primary practice is Montage Medical Group in Carmel, California. Dr. Vierra is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is Montage Medical Group. Dmand AI also links Dr. Vierra to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vierra practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Vierra's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Vierra's licenses on file in 2 states: California and Hawaii.

Dmand AI lists abdominal hernia repair surgery, bariatric surgery, colonoscopy, colon removal, esophagus, stomach, or upper small intestine surgery, gallbladder removal, gastrointestinal bleeding and groin hernia surgery among the conditions Dr. Vierra treats.

CMS data shows 722 Medicare services from Dr. Vierra across 14 procedure codes in 2024, for 400 Medicare patients. Medicare paid $98,542 for them.

CMS counts 400 Medicare patients who saw Dr. Vierra in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Vierra's median patient age at 57, with 66% women.

In 2024, Dr. Vierra wrote 351 Medicare Part D claims for 133 patients. 90% of them were for generic drugs. CMS names the drug for 187 of them, across 5 drugs with 11 or more claims each, at $17,649 in total drug cost. In 2023, CMS named 181 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Vierra for performance year 2024, reported as part of a group. Dr. Vierra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vierra as offering telehealth. CMS counts 19 procedures of hernia repair - groin (open) by Dr. Vierra, more than 96% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Vierra in 2010. The most frequent topics are Fluorouracil, Pancreatic Neoplasms and Receptors, Chemokine. Dr. Vierra has published most often in Int J Radiat Oncol Biol Phys. Dr. Vierra's most frequent co-authors are George A. Fisher, MD, Eugene Butcher, MD and James Matthew Ford, MD.

CMS Open Payments shows 13 general payments to Dr. Vierra from 8 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $224.

Dmand AI lists 2 awards for Dr. Vierra, most recently CMS Stage 1 2012 in 2012.

Dr. Vierra graduated from Harvard Medical School in 1985. Dr. Vierra is a member of ACS.

Dr. Vierra is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.